Nancy A. Rigotti, MD
Potential Financial Conflicts of Interest:Consultancies: Pfizer, Sanofi-Aventis. Grants received: Nabi Biopharmaceuticals, Pfizer, Sanofi-Aventis.
Requests for Single Reprints: Nancy A. Rigotti, MD, Massachusetts General Hospital, 50 Staniford Street, Boston, MA 02114; e-mail, firstname.lastname@example.org.
Rigotti N.; The Future of Tobacco Treatment in the Health Care System. Ann Intern Med. 2009;150:496-497. doi: 10.7326/0003-4819-150-7-200904070-00011
Download citation file:
Published: Ann Intern Med. 2009;150(7):496-497.
We face a conundrum in our efforts to treat tobacco use and dependence, the leading preventable cause of death in the United States (1). Most smokers know they should quit, 70% say they want to quit, and 40% report having tried to do so in the past year (2, 3). Yet the large majority of these quit attempts failed to produce long-term tobacco abstinence, despite the availability of effective treatments. The reason? Most smokers trying to quit do not use these treatments (4).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Coronary Risk Factors, Smoking.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only